Sabine Royalty Trust Ár/értékesítés
Mi az Sabine Royalty Trust Ár/értékesítés?
A Ár/értékesítés az Sabine Royalty Trust - 10.47
Mi a Ár/értékesítés meghatározása?
Az ár / árbevétel arány a vállalat részvényeinek árbevételéhez képest.
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Ár/értékesítés a Energy szektor a NYSE-on cégekben a Sabine Royalty Trust -hoz képest
ár/értékesítés -hoz hasonló cégek Sabine Royalty Trust
- Maverix Metals nak Ár/értékesítés 10.44 van
- Nalwa Sons Investments nak Ár/értékesítés 10.45 van
- Duff & Phelps Utility and Infrastructure Fund Inc nak Ár/értékesítés 10.46 van
- ABIONYX Pharma SA nak Ár/értékesítés 10.46 van
- Altius Minerals nak Ár/értékesítés 10.47 van
- ClearSign Technologies Corp nak Ár/értékesítés 10.47 van
- Sabine Royalty Trust nak Ár/értékesítés 10.47 van
- HengTen Networks nak Ár/értékesítés 10.47 van
- Inspire Medical Systems Inc nak Ár/értékesítés 10.48 van
- Flaherty & Crumrine Dynamic Preferred and Income Fund Inc nak Ár/értékesítés 10.48 van
- Editas Medicine Inc nak Ár/értékesítés 10.48 van
- NetScientific plc nak Ár/értékesítés 10.48 van
- Feiyang Intl Hldg Grp Ltd nak Ár/értékesítés 10.48 van